Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 1

Interventions

pembrolizumab 66 Carboplatin 65 Paclitaxel 54 Magnetic Resonance Spectroscopy 45 Cisplatin 45 Specimen Handling 43 Gemcitabine 36 Docetaxel 31 Bevacizumab 31 Leucovorin 29 Doxorubicin 29 Dexamethasone 28 Fluorouracil 27 Pemetrexed 26 Cyclophosphamide 26 Oxaliplatin 24 Radiation 23 durvalumab 22 Radiotherapy 22 Letrozole 22 Etoposide 22 Nivolumab 21 Irinotecan 21 Vincristine 20 Rituximab 20 Capecitabine 20 Taxes 19 Prednisone 19 Lenalidomide 19 130-nm albumin-bound paclitaxel 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Immune Checkpoint Inhibitors × 30 days × Clear all

NCT07590024 2026-06-04

RAIRI-NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Recruiting

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡